<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>7d645d43-0f23-40e1-8937-e63ccc6f0795</id>
  <name>AHS OGN ADULT CDEP VTE Prophylaxis Hip Fracture Pre Procedure Adult</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;&lt;em&gt;&amp;nbsp;VTE Prophylaxis_Surgery Adult Order Panel&lt;/em&gt;&lt;/p&gt;</value>
      </item>
      <item>
        <key>Technical.ﻩ Technical Traceability</key>
        <value>{~AHSID~7d645d43-0f23-40e1-8937-e63ccc6f0795~NAME~AHS OGN ADULT CDEP VTE Prophylaxis Hip Fracture Pre Procedure Adult}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Clinical Decision Support&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Clinical Decision Support&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:0px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;strong&gt;Risk Assessment / Scoring Tools / Screening:&amp;nbsp;&lt;/strong&gt;&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;em&gt;Note: All patients with hip fracture are at higher risk of VTE and should be considered for early initiation and extended prophylaxis&amp;nbsp;&lt;/em&gt;&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;u&gt;&lt;strong&gt;Recommendation:&lt;/strong&gt;&lt;/u&gt; Patients undergoing major surgery should receive prophylaxis at least during hospital stay and longer for those with additional risk factors.&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;table border=&quot;1&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Low Risk&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Non-major surgery in patients less than 40 years old with no risk factors&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Moderate Risk&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;1.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Non-major surgery with additional risk factors, or:&lt;/p&gt;&lt;p&gt;2.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Age 40-60 years old&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;High Risk&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;1.&amp;nbsp;&amp;nbsp;&amp;nbsp; Age greater than 60 years old, or:&lt;/p&gt;&lt;p&gt;2.&amp;nbsp;&amp;nbsp;&amp;nbsp; 40-60 years old with additional risk factors&lt;/p&gt;&lt;p&gt;3.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Major surgery in patients aged less than 40 with multiple risk factors&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;Very High Risk&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;1.&amp;nbsp;&amp;nbsp;&amp;nbsp; Major surgery in patients with multiple risk factors or:&lt;/p&gt;&lt;p&gt;2.&amp;nbsp;&amp;nbsp;&amp;nbsp; Any patient having hip or knee arthroplasty, or:&lt;/p&gt;&lt;p&gt;3.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Major trauma or spinal cord injury.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&lt;br&gt;&lt;u&gt;&lt;strong&gt;Risk Factors:&lt;/strong&gt;&lt;/u&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;u&gt;Major Risk Factors:&amp;nbsp;&lt;/u&gt;Major surgery, trauma, ischemic stroke or paralysis, spinal cord injury, previous VTE, congenital and/or acquired thrombophilia states, or active cancer and its treatment, active COVID-19 infection&lt;/p&gt;&lt;p&gt;&lt;u&gt;Minor Risk Factors:&amp;nbsp;&lt;/u&gt;Age greater than 40 years, estrogen therapy, nephrotic syndrome, pregnancy/postpartum, prolonged immobility greater than 24 hours, general anesthesia longer than 1 hour, severe respiratory disease, collagen vascular disease, inflammatory bowel disease, congestive heart failure, obesity, sepsis, varicose veins&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;u&gt;&lt;strong&gt;Contraindications:&lt;/strong&gt;&lt;/u&gt;&lt;/p&gt;&lt;p&gt;Uncontrolled hypertension, Bleeding disorders (platelets less than 50 x 109/L), Recent intracranial or intraocular hemorrhage, Lumbar puncture within 24 hours, Active bleeding, Heparin-induced thrombocytopenia (HIT)&lt;/p&gt;&lt;p&gt;For patients on heparins, certain drugs can enhance bleeding tendency: acetylsalicylic acid (ASA) and other antiplatelet agents (e.g. clopidogrel, ticagrelor), and nonsteroidal anti-inflammatory drugs (NSAIDs) (particularly ketorolac). This is particularly relevant for patients with intrathecal catheters for analgesia where low molecular weight heparin (LMWH) or unfractionated heparin(UFH ) must NOT be used in conjunction with antiplatelet agents.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;u&gt;&lt;strong&gt;Caution –&amp;nbsp;Management of heparins with spinal punctures:&lt;/strong&gt;&lt;/u&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;table cellpadding=&quot;1&quot; cellspacing=&quot;1&quot; border=&quot;1&quot; style=&quot;width:720px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;width:113px&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td style=&quot;width:133px&quot;&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:0px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;text-align:left; vertical-align:top&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td style=&quot;text-align:left; vertical-align:top&quot;&gt;&lt;p&gt;Time Before Puncture/Catheter Manipulation or Removal&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;td style=&quot;width:172px&quot;&gt;Use of anticoagulant in Patients with Indwelling Neuraxial Catheter&lt;/td&gt;&lt;td style=&quot;width:111px&quot;&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:143px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:143px&quot;&gt;&lt;p&gt;Time After Puncture/Catheter Manipulation or Removal&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;td style=&quot;width:186px&quot;&gt;Laboratory Tests&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:113px&quot;&gt;Unfractionated Heparin (UFH) - for prophylaxis, less than 15,000 units /day&lt;/td&gt;&lt;td style=&quot;width:133px&quot;&gt;4 to 6 hours&lt;/td&gt;&lt;td style=&quot;width:172px&quot;&gt;Acceptable&lt;/td&gt;&lt;td style=&quot;width:111px&quot;&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:0px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;1 hour&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;td style=&quot;width:186px&quot;&gt;Platelets during treatment for greater than 3 days&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:113px&quot;&gt;Low Molecular Weight Heparin (LMWH) - for prophylaxis&lt;/td&gt;&lt;td style=&quot;width:133px&quot;&gt;12 hours&lt;/td&gt;&lt;td style=&quot;width:172px&quot;&gt;&lt;p&gt;For single daily dosing –&amp;nbsp;catheter acceptable&lt;/p&gt;&lt;p&gt;(remove catheter 12 hours prior to next dose of LMWH, and subsequent dose should be greater than 4 hours after removal)&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;For Twice daily dosing –&amp;nbsp;Do not maintain catheter&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:111px&quot;&gt;&lt;p&gt;First postoperative dose at least 12 hours after neuraxial puncture and at least 4 hours after removal&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Subsequent dose at least 24 hours after the first dose&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:186px&quot;&gt;Platelets during treatment for greater than 3 days&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Dose Adjustment: &lt;/strong&gt;Consider adjusting dosage for extremes of weight and renal dysfunction. Adjusted Dosing orders are available in this order set.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;In order to avoid the higher risk of heparin-induced thrombocytopenia, use of unfractionated heparin should be minimized.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk of Bleeding Contraindications&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1 and name/value=&apos;Section supporting context #1&apos;]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pre-Op Prophylaxis&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Additional Therapy for Patients With Very High VTE Risk&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="VTE Prophylaxis - Hip Fracture Pre Procedure Adult">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Clinical Decision Support">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Treatment Options">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="High Risk of Bleeding Contraindications">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" max="1" path="/items" name="Section supporting context #1"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="When bleeding risk decreases, pharmacologic thromboprophylaxis should be substituted for or added to mechanical thromboprophylaxis"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="528e44bc-af74-465f-a535-3a62f4bb1d0c" concept_name="NURINT Sequential Compression Device [NUR536] IP Order" max="1" path="/items" name="Sequential Compression Device; Apply, Until discontinued. For patients with a high risk of bleeding, use SCDs at least until the initial risk of bleeding decreases"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="df94fc61-7e8a-4890-8269-d3cea3b1064f" concept_name="NURINT AntiEmbolism Stockings [NUR560] IP Order" max="1" path="/items" name="AntiEmbolism Stockings; Apply, Bilateral, Until discontinued"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #4"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Pre-Op Prophylaxis">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="For patients whose surgery is delayed more than 24 hours, select ONE of the following orders:"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin injection for bolus - units, units/kg/dose; 5000 unit/0.5 ml injection, subcutaneous, every 12 hours, Hold dose morning of surgery."/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin injection for bolus - units, units/kg/dose; If patient greater than 100 kg, 5000 unit/0.5 ml injection, subcutaneous, every 8 hours, Hold dose morning of surgery."/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; 2500 unit/0.25 ml injection, subcutaneous, every 24 hours, Hold dose for a minimum of 12 hours before surgery."/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Additional Therapy for Patients With Very High VTE Risk">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Consider selecting ONE of the following additional therapy orders:"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="5acbaebd-5dbd-4d88-901a-999df170f41c" concept_name="SUP Sequential compression device unit [EQ102] Order" max="1" path="/items" name="Sequential compression device unit; Recommended for highest risk patients as additional therapy."/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="df94fc61-7e8a-4890-8269-d3cea3b1064f" concept_name="NURINT AntiEmbolism Stockings [NUR560] IP Order" max="1" path="/items" name="AntiEmbolism Stockings; Until discontinued"/>
      </Item>
    </Item>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">5DC6E2FC9E91ADD05E7C5B3E06F83D23</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.booleanorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">56B5A2F2979B94F83C97E66B46679692</digest>
  </integrity_checks>
</template>